Logo do repositório
 
Publicação

Prevalence of drug use during sex amongst MSM in Europe

dc.contributor.authorRosińska, Magdalena
dc.contributor.authorGios, Lorenzo
dc.contributor.authorNöstlinger, Christiana
dc.contributor.authorVanden Berghe, Wim
dc.contributor.authorMarcus, Ulrich
dc.contributor.authorSchink, Susanne
dc.contributor.authorSherriff, Nigel
dc.contributor.authorJones, Anna Marie
dc.contributor.authorFolch, Cinta
dc.contributor.authorDias, Sonia
dc.contributor.authorVelicko, Inga
dc.contributor.authorMirandola, Massimo
dc.contributor.authorGama, Ana
dc.contributor.authorPiedade, J
dc.contributor.authorSialon II Network
dc.contributor.institutionInstituto de Higiene e Medicina Tropical (IHMT)
dc.contributor.institutionGlobal Health and Tropical Medicine (GHTM)
dc.contributor.institutionTB, HIV and opportunistic diseases and pathogens (THOP)
dc.contributor.pblElsevier
dc.date.accessioned2022-06-22T22:19:08Z
dc.date.available2022-06-22T22:19:08Z
dc.date.issued2018-05
dc.description.abstractBackground: Substance use has been consistently reported to be more prevalent amongst Men who have Sex with Men (MSM) compared to the general population. Substance use, in particular polydrug use, has been found to be influenced by social and contextual factors and to increase the risk of unprotected intercourse among MSM. The objective of this analysis was to investigate the prevalence and predictors of drug use during a sexual encounter and to identify specific prevention needs. Methods/design: A multi-site bio-behavioural cross-sectional survey was implemented in 13 European cities, targeting MSM and using Time-Location Sampling and Respondent-Driven Sampling methods Multivariable multi-level logistic random-intercept model (random effect of study site) was estimated to identify factors associated with the use of alcohol, cannabis, party drugs, sexual performance enhancement drugs and chemsex drugs. Results: Overall, 1261 (30.0%) participants reported drug use, and 436 of 3706 (11.8%) reported the use of two or more drugs during their last sexual encounter. By drug class, 966 (23.0%) reported using sexual performance enhancement drugs, 353 (8.4%) - party drugs, and 142 (3.4%) the use of chemsex drugs. Respondents who reported drug use were more frequently diagnosed with HIV (10.5% vs. 3.9%) before and with other STIs during the 12 months prior to the study (16.7% vs. 9.2%). The use of all the analysed substances was significantly associated with sexual encounter with more than one partner. Discussion: Substance and polydrug use during sexual encounters occurred amongst sampled MSM across Europe although varying greatly between study sites. Different local social norms within MSM communities may be important contextual drivers of drug use, highlighting the need for innovative and multi-faceted prevention measures to reduce HIV/STI risk in the context of drug use.en
dc.description.versionpublishersversion
dc.description.versionpublished
dc.format.extent10
dc.format.extent600049
dc.identifier.doi10.1016/j.drugpo.2018.01.002
dc.identifier.issn0955-3959
dc.identifier.otherPURE: 3952412
dc.identifier.otherPURE UUID: 9845b418-38d9-4bea-949a-7a5887f2189d
dc.identifier.otherScopus: 85041619647
dc.identifier.otherPubMed: 29402683
dc.identifier.otherORCID: /0000-0001-5085-0685/work/131110213
dc.identifier.urihttp://hdl.handle.net/10362/140562
dc.identifier.urlhttps://www.scopus.com/pages/publications/85041619647
dc.language.isoeng
dc.peerreviewedyes
dc.subjectDrug use
dc.subjectEurope
dc.subjectMSM
dc.subjectRecreational drug use
dc.subjectRespondent-driven sampling
dc.subjectTime-location sampling
dc.subjectMedicine (miscellaneous)
dc.subjectHealth Policy
dc.subjectSDG 3 - Good Health and Well-being
dc.titlePrevalence of drug use during sex amongst MSM in Europeen
dc.title.subtitleResults from a multi-site bio-behavioural surveyen
dc.typejournal article
degois.publication.firstPage231
degois.publication.lastPage241
degois.publication.titleInternational Journal of Drug Policy
degois.publication.volume55
dspace.entity.typePublication
rcaap.rightsopenAccess

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
Prevalence_of_drug_use_during_sex_amongst_MSM_in_Europe.pdf
Tamanho:
585.99 KB
Formato:
Adobe Portable Document Format